Results 31 to 40 of about 3,364,352 (377)

Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers [PDF]

Clinical and Experimental Allergy, 2013
Siwei Dong, D.-S. Acouetey, R.-M. Guéant-Rodriguez, Denis Zmirou‐Navier, Thomas Rémen, M. Blanca, Paul‐Michel Mertès, Jean‐Louis Guéant   +7 more
openalex   +2 more sources

A Cross-Sectional survey on Knowledge, Attitude, and Practices of Neuromuscular Monitoring among Indian Anesthesiologists

Archives of Anesthesia and Critical Care, 2022
Background: The utility of Neuromuscular monitoring (NMT) has not been studied in Indian scenario till date. We did a survey to evaluate the knowledge, attitude, practices of NMT among Indian anesthesiologists. Methods: A questionnaire-based google form
Sonal Goyal, Bhavna Gupta
doaj   +1 more source

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: Current perspectives [PDF]

, 2017
The number of elderly patients is increasing worldwide. This will have a significant impact on the practice of anesthesia in future decades. Anesthesiologists must provide care for an increasing number of elderly patients, who have an elevated risk of ...
Bertoncello, Francesco, Carron, Michele, Ieppariello, Giovanna   +2 more
core   +1 more source

Sugammadex: Breaking Through Residual Paralysis after Neostigmine’s Limits [PDF]

Journal of Clinical and Diagnostic Research
Persistent neuromuscular blockade following the use of Neuromuscular Blocking Agents (NMBAs) remains a significant postoperative concern, often resulting in delayed recovery and prolonged stays in the Post- Anaesthesia Care Unit (PACU).
Aparna Bagle, Sania Rodrigues
doaj   +1 more source

Sugammadex for reversal of neuromuscular blockade: A retrospective analysis of clinical outcomes and cost-effectiveness in a single center [PDF]

, 2016
OBJECTIVE: The aim of the study is to evaluate the clinical and economic impact of introducing a rocuronium-neostigmine-sugammadex strategy into a cisatracurium-neostigmine regimen for neuromuscular block (NMB) management.
BARATTO, FABIO, CARRON, MICHELE, ORI, CARLO, ZARANTONELLO, FRANCESCO   +3 more
core   +1 more source

Inclusion body myositis: therapeutic approaches. [PDF]

, 2012
The idiopathic inflammatory myopathies are a heterogeneous group of diseases that include dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and other less common myopathies.
Aggarwal, Rohit, Oddis, Chester V
core   +1 more source

Treatment of Gastrointestinal Sphincters Spasms with Botulinum Toxin A

Toxins, 2015
Botulinum toxin A inhibits neuromuscular transmission. It has become a drug with many indications. The range of clinical applications has grown to encompass several neurological and non-neurological conditions.
Giuseppe Brisinda, Nicola Sivestrini, Giuseppe Bianco, Giorgio Maria   +3 more
doaj   +1 more source

A fresh look at paralytics in the critically ill: real promise and real concern. [PDF]

, 2012
Neuromuscular blocking agents (NMBAs), or "paralytics," often are deployed in the sickest patients in the intensive care unit (ICU) when usual care fails.
Kenyon, Nicholas J, Price, David, Stollenwerk, Nicholas   +2 more
core   +2 more sources

A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases

Toxins, 2015
This study aims to determine the most efficacious dose of Botulinum neurotoxin type A (BoNT-A) in reducing sialorrhea in Asian adults with neurological diseases. A prospective, double-blind randomized controlled trial was conducted over 24 weeks. Thirty
Mazlina Mazlan, Shivani Rajasegaran, Julia Patrick Engkasan, Ouzreiah Nawawi, Khean-Jin Goh, Saini Jeffery Freddy   +5 more
doaj   +1 more source

Tracheal intubation without neuromuscular blocking drugs in children [PDF]

, 2009
No abstract ...
Aantaa, Abdallah, Aouad, Batra, Blair, Blair, Bode, Crawford, De Fatima De Assuncao Braga, Drenger, Duman, Gupta, Hansen, Hansen, Helbo-Hansen, Hiller, Humphries, Inomata, Inomata, Inomata, Inomata, Inomata, Klemola, Lerman, Meakin, Mertes, Min, Morgan, Nishina, O’Brien, Politis, Politis, Robinson, Senel, Simon, Splinter, Steyn, Swan, Taguchi, Thwaites, Wappler, Warner, Watcha, Watcha, Watcha, Watcha, Weber, Woods, Xue, Xue, Xue, Xue, Yaguchi   +52 more
core   +1 more source